Full Text View
Tabular View
No Study Results Posted
Related Studies
Intraocular Bevacizumab (Avastin) for Rubeosis Iridis
This study has been completed.
Study NCT00557232   Information provided by Instituto de Olhos de Goiania

First Received on November 8, 2007.   Last Updated on November 25, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glaucoma
Rubeosis Iridis
Additional conditions recognized in this trial
Glaucoma, Neovascular
Retinal Vein Occlusion
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Eye Diseases
Ocular Hypertension
Retinal Diseases
Thrombosis
Vascular Diseases
Venous Thrombosis
Interventions listed in this trial
bevacizumab
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Instituto de Olhos de Goiania


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services